A Streptococcus sanguis 133-79 adhesin identified by the monoclonal antibody 1.1 (MAb 1.1) binds both saliva-coated hydroxylapatite (sHA) and platelets. The complementary binding site(s) for the adhesin was identified by the anti-idiotypical MAb 2.1. To learn if this adhesion system, marked by the antiadhesin MAb 1.1 and anti-binding site MAb 2.1, is commonly used by strains within the sanguis group and other viridans group streptococci, 42 strains from seven species were tested. Strains that bind to both sHA and platelets use the same adhesin and binding site epitopes. Strains that do not adhere to platelets rely on other adhesin specificities to bind to sHA.
final concentration of 100 g/ml. Bacterial colonies were removed with sterile swabs and suspended in TES buffer. The suspension was adjusted to an optical density of 0.1 at 620 nm. Substrate solution (20 l) was mixed with 50 l of bacterial suspension in wells of a flat-bottomed, clear microdilution plate and incubated at 37°C for 3 h. Degradation of substrates (release of 4-methylumbelliferyl) was visualized by viewing the plates under a long-wave-length UV lamp; sialidase-positive strains produced blue fluorescence.
Preparation of MAbs. MAbs were prepared as reported previously (9, 10) . Briefly, MAbs against S. sanguis adhesin (MAb 1.1) were raised by immunizing BALB/c mice intraperitoneally with live cells of strain 133-79. MAb 1.1 was screened against both adhesive and nonadhesive strains and tested for the ability to inhibit adhesion of S. sanguis to both platelets and sHA. To produce antiidiotypic MAbs, the hybridoma producing MAb 1.1 was injected intraperitoneally into BALB/c mice as described previously (10) . The enlarged spleens were harvested and MAb 2.1 hybridomas were prepared. MAb 2.1 was screened in indirect ELISA for reaction with rabbit polyclonal IgG antibodies against the 87-kDa adhesin antigen and also tested for inhibition of S. sanguis adhesion to platelets and sHA.
Indirect ELISA. Streptococcal strains were screened by ELISA for reaction with MAb 1.1 as described by Elder and Fives-Taylor (6), with slight modifications (10) . The bacteria were washed in PBS, resuspended in sodium carbonate buffer (pH 9.6), added to 96-well flat-bottom microtiter plates (Costar, Cambridge, Mass.) at 5 ϫ 10 6 cells/well, and allowed to incubate overnight at 4°C. The plates were dried at room temperature (RT) and stored at 4°C. Immediately before use in ELISA, the plates were washed three times with PBS with 0.05% Tween 20 (PBST) and blocked with 1% bovine serum albumin (Sigma) for 1 h at RT. Next, 100 l of a 1:4 dilution of MAb 1.1 culture supernatant (containing about 1 g of IgG1/ml) was added to each well and incubated for 3 h at RT. After three additional washes with PBST, a 1:3,000 dilution of goat anti-murine IgG conjugated with alkaline phosphatase (Bio-Rad, Richmond, Calif.) was added at 100 l/well. After 2 h of incubation at RT, the wells were washed and the substrate was added at 150 l/well. The plates were allowed to stand at RT for 1 h and then read at 405 nm. Reaction of nonspecific mouse IgG (0.25 g/ml, 100 l/well) with each strain served as the negative control (background).
Adhesion assays. All procedures for the platelet-bacterium adhesion assay were performed as described previously (11) . In brief, platelets from outdated platelet-rich plasma (PRP) (American Red Cross Blood Center, St. Paul, Minn.) were washed with PBS. Washed platelets and washed streptococcal cells were incubated together or alone (controls) in microwells; the small clusters of adhering platelets and bacteria were separated from noninteracting particles by centrifugation. The sedimentation of adhering mixtures relative to controls was quantitated by the following formula: percent adhesion ϭ 100 ϫ {1 Ϫ [mixture A 620 /(bacterium A 620 ϩ washed-platelet A 620 )/2]}. Based on previous studies of the variability of the method (14) , only adhesion scores of Ն20% were considered positive.
Adhesion of streptococcal cells to sHA was assayed by a modification of the method used by Liljemark and coworkers (21, 22) and Tellefson and Germaine (30) . The assay was performed in 1.5-ml polypropylene microcentrifuge tubes (24) . By DNA fingerprinting, the parent strain, 133-79, and variants S1219 and E1219 showed the same lineage (25 9 cells/ml. The specific activity for labeled streptococcal strains varied from 752 Ϯ 22 (mean Ϯ standard deviation) to 9,792 Ϯ 152 bacteria per cpm. The data are presented as a percentage of total bacterial input (10 9 cells) adhering to 10 mg of sHA and were calculated as follows: [(radioactivity associated with sHA ϫ specific activity)/10
9 cells] ϫ 100. Given the sensitivity and reproducibility of the method, an adhesion score of Ն6.5% was considered positive.
To learn if the strains adhere to the same binding site, platelets (10 9 /ml) or sHA (10 mg/ml) was preincubated for 30 min with 1% bovine serum albumin and then incubated for 1 h at RT with MAb 2.1 (2 nmol of IgG/10 9 platelets/100 l or 33.3 pmol of IgG/10 mg of sHA). Nonbinding MAb 2.1 was removed by washing, and streptococcal adhesion to platelets or sHA was tested. The percent inhibition of streptococcal adhesion was calculated as follows: [(adhesion PB Ϫ adhesion MAb )/adhesion PB ] ϫ 100, where adhesion PB occurs in the presence of buffer and adhesion MAb occurs in the presence of added antibody.
RESULTS
We confirmed the phenotypes of representative strains from our panel (Table 1 ). Several strains were previously classified as S. sanguis (14) but based on additional criteria were considered for reassignment. Strain L31 (inulin fermentation positive and arginine and esculin hydrolysis positive) and E1219, an erythromycin-resistant variant of strain 133-79, were amylase binding positive. Based on its ability to bind amylase, strain L31 was reclassified as S. gordonii. Strain E1219, which was also amylase binding positive, was not reassigned because the parent strain was confirmed to be S. sanguis. Strain L13 (inulin fermentation negative, raffinose positive, and arginine and esculin hydrolysis negative) showed sialidase activity and was reassigned as S. oralis.
Of 16 S. sanguis strains, 50% were adhesion positive with both platelets (Ͼ20% adhesion) and sHA (Ͼ6.5% adhesion) ( Table 2 ). Among the seven species surveyed, 13 of 42 strains (31%) adhered to platelets and 21 (50%) adhered to sHA. All strains that bound to platelets also adhered to sHA and could be identified as MAb 1.1 binding positive ( Table 3 ). Strains that were MAb 1.1 binding negative did not adhere to platelets. Conversely, sHA adhesion-positive, platelet adhesionnegative strains also did not react with MAb 1.1.
Binding of MAb 1.1 by all strains was highly correlated with their ability to adhere to platelets (r ϭ 0.949) (Fig. 1) . When strains that only adhered to sHA were excluded from the analysis, the abilities of the remaining strains to adhere to sHA and bind with MAb 1.1 were strongly related (r ϭ 0.897) (Fig.  2) . When all strains were included in the analysis, the correlation between the ability to adhere to sHA and binding with MAb 1.1 was lower (r ϭ 0.481).
For all streptococcal strains that bound MAb 1.1, adhesion to sHA and platelets could be inhibited by the anti-idiotypic MAb 2.1 ( Table 4 ). Examples of MAb 1.1-positive strains inhibited in adhesion activities by MAb 2.1 were noted in most taxa of viridans group streptococci tested. Inhibition of streptococcal adhesion to sHA and platelets by MAb 2.1 was highly correlated with the ability of strains to bind MAb 1.1 (r ϭ 0.832 and 0.777, respectively) (Fig. 3) .
DISCUSSION
Of the S. sanguis strains and viridans group streptococci tested, every strain that bound to platelets also adhered to sHA. Adhesion to sHA and platelets was shown previously to be inhibited by MAb 1.1 in a dose-dependent manner (9, 10). MAb 1.1 reacts with a two-domain adhesin on S. sanguis 133-79 (9); this adhesin is required for interactions with human platelets (10) and sHA (9) . The adhesin-specific MAb 1.1 reacts with strains that adhere to both platelets and sHA (9, 10) , suggesting that the same functional adhesin epitope is expressed. MAb 1.1, therefore, served in this study as a marker for this functional adhesin epitope. While strains vary in the amount of MAb 1.1 required for saturation, the current data show that the MAb 1.1-positive adhesin epitope is widely expressed among the viridans group streptococci. MAb 1.1-positive strains also adhere to these two disparate substrates. Other strains are MAb 1.1-negative. As expected based on work with S. sanguis 133-79, these strains failed to bind to platelets (10) . For those MAb 1.1-negative strains that adhered well to sHA, an alternative adhesin specificity is implied to function. The anti-idiotypical MAb 2.1 was prepared by immunization of syngeneic mice with MAb 1.1 (10) . MAb 2.1 should mimic immunochemically the adhesin epitope recognized by MAb 1.1. Hence, MAb 2.1 should bind the immunochemically complementary binding sites for the S. sanguis adhesin marked by MAb 1.1 on adhesion substrates such as platelets and sHA. Indeed, MAb 2.1 bound to sHA and platelets to inhibit adhesion of MAb 1.1-positive strains. MAb 2.1 identifies, therefore, an immunochemically specific binding site for adhesion of MAb 1.1-positive viridans group streptococci. These platelet and sHA binding sites or receptors (identified by the antiidiotype MAb 2.1) for streptococcal cells are likely to share essential structural features but to consist of very different proteins. Alternative binding sites on sHA for viridans group streptococci are also implied to function for MAb 1.1-negative strains.
The oral streptococci express a constellation of adhesins (17) , several of which may be MAb 1.1 reactive (9) . Among the better-characterized families of adhesins are P1 (2, 16), CshA and -B (23), and FimA (8, 20) . In addition, S. gordonii expresses an amylase binding protein (27) . While it is clear that the sanguis group expresses many protein adhesins, this report demonstrates a novel, epitope-specific, functional conservation.
The data indicate that MAb 1.1 and the corresponding antiidiotypic MAb 2.1 mark a specific adhesion system for viridans group streptococci. The adhesion system is comprised of an adhesin epitope and its structurally complementary binding site or receptor. Of the 42 strains of viridans group streptococci tested, at least 13 employed this adhesion system for platelets and sHA. The ability to use the MAb 1.1-MAb 2.1 adhesion system was independent of taxon. To consider taxonomic restrictions on this trait, the classification of many of the strains in the panel was reevaluated on the basis of amylase binding (3, 4, 19) and sialidase activity (1) . The original taxonomy for the strains in the panel employed the strategy of Kilian et al. (18) . For several of the 16 strains for which taxonomic identity was reevaluated, the classification could be questioned. Strain L31, which produced acid from inulin, hydrolyzed arginine and esculin, and bound ␣-amylase, was reclassified from S. sanguis to S. gordonii. S. sanguis-like strains that bind amylase are generally classified as S. gordonii or other species (4, 19) . In contrast, strain L13, which was negative for inulin fermentation, hydrolysis of arginine and esculin, and amylase binding, fermented (24) and the variant, which was selected after growth in the presence of erythromycin, was shown to be from the parental lineage by DNA fingerprinting (25) . Further study of strain E1219 will be necessary to make a correct taxonomic assignment. Strain L4123 was classified as S. sanguis, even though it did not hydrolyze arginine. The assignment of this strain is clearly uncertain, but the limited scope of phenotypic characteristics examined precluded a decisively better assignment. Hence, most of our S. sanguis strains remain assigned to that taxon, except for strains L13 and L31. It is clear, however, that expression of the MAb 1.1-MAb 2.1 adhesion system, which confers the ability of viridans group streptococci to adhere to both platelets and sHA, is independent of taxon and is common among the viridans group streptococci.
